(Q34333899)

1 August 2017

1 reference

title

Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder (English)

1 reference

1 August 2017

0 references

2

Caroline M Perry

1 reference

1 August 2017

Tracy Swainston Harrison

series ordinal

1

1 reference

1 August 2017

1 January 2004

1 reference

1 August 2017

1 reference

1 August 2017

64

1 reference

1 August 2017

1715-1736

1 reference

1 August 2017

15

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464150-00010

1 August 2017

0 references

cites work

Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action.

1 reference

12 December 2020

Long-term Treatment of Schizoaffective Disorder: Review and Recommendations

1 reference

12 December 2020

Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Tolerability of atypical antipsychotics

1 reference

12 December 2020

In vivo canine model comparison of cardiohemodynamic and electrophysiological effects of a new antipsychotic drug aripiprazole (OPC-14597) to haloperidol

1 reference

12 December 2020

Efficacy of newer generation antipsychotics in the treatment of schizophrenia

1 reference

12 December 2020

Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers

1 reference

12 December 2020

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

1 reference

12 December 2020

Aripiprazole for schizophrenia

1 reference

12 December 2020

7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.

1 reference

12 December 2020

Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum

1 reference

12 December 2020

Dopamine partial agonists: a new class of antipsychotic

1 reference

12 December 2020

Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 1, "Goldilocks" actions at dopamine receptors.

1 reference

12 December 2020

Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study.

1 reference

12 December 2020

Quetiapine. A review of its use in the management of schizophrenia

1 reference

12 December 2020

Partial agonistic effects of OPC-14597, a potential antipsychotic agent, on yawning behavior in rats.

1 reference

12 December 2020

Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride

1 reference

12 December 2020

Atypical antipsychotics: revolutionary or incremental advance?

1 reference

12 December 2020

Mechanism of new antipsychotic medications: occupancy is not just antagonism

1 reference

12 December 2020

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

12 December 2020

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

1 reference

12 December 2020

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

1 reference

12 December 2020

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

1 reference

12 December 2020

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

12 December 2020

Inhibition by aripiprazole of dopaminergic inputs to striatal neurons from substantia nigra.

1 reference

12 December 2020

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

1 reference

12 December 2020

Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro -2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland

1 reference

12 December 2020

Biological perspectives. Aripiprazole: a third generation of antipsychotics begins?

1 reference

12 December 2020

An overview of the treatment of schizoaffective disorder

1 reference

12 December 2020

Antagonizing effects of a novel antipsychotic quinolinone derivative (OPC-14597) on dopaminergic inhibition of neuronal activities in the nucleus accumbens

1 reference

12 December 2020

1 reference

12 December 2020

Inhibition by a putative antipsychotic quinolinone derivative (OPC-14597) of dopaminergic neurons in the ventral tegmental area.

1 reference

12 December 2020

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes

1 reference

12 December 2020

Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study

1 reference

12 December 2020

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

12 December 2020

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

1 reference

12 December 2020

Outcome in schizophrenia: beyond symptom reduction.

1 reference

12 December 2020

10.2165/00003495-200464150-00010

Identifiers

DOI

1 reference

PubMed ID

15257633

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

15257633